AEterna Zentaris Inc. (AEZS)

[kei]

~ hello :) the stock market (especially small-cap bio) is moody and anything can happen..with regard to the agreement with Sinopharm A-Think, there are 3 key points in my view...1) aezs gets real money (revenue)...2) the Sinopharm is the largest pharma in china and Sinopharm A-Think is a subsidiary of Sinopharm. (china has 1.3 billions population)...and 3) is below the gm from sinopharm A-think's talk..(plese read it carefully...i highlighted) ...all imo and my view (btw, i'm here for a swing play as i mentioned here yesterday & good luck to you and all)

Dr. Jia Zhidan, General Manager of Sinopharm A-Think, similarly indicated that, "We believe zoptarelin doxorubicin can pioneer the use of conjugate technology in advanced endometrial cancer, as earlier clinical development with this product has shown encouraging data in overall survival and tolerability. We also believe that zoptarelin doxorubicin has the potential to become our star product in the future. As an enterprise committed to building up a professional anti-cancer platform, we would like to look for additional promising products such as zoptarelin doxorubicin, and are more than willing to cooperate with excellent companies such as Aeterna Zentaris. We hope to engage additional cooperation opportunities in the future, benefitting more cancer patients."
link: http://ih.advfn.com/p.php?pid=nmona&article=64618387